Found: 46
Select item for more details and to access through your institution.
Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 58, n. 1, p. 202, doi. 10.1093/jac/dkl152
- By:
- Publication type:
- Article
Are fluoroquinolone-susceptible isolates of <it>Streptococcus pneumoniae</it> really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 4, p. 769, doi. 10.1093/jac/dki315
- By:
- Publication type:
- Article
Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.
- Published in:
- Drugs, 2021, v. 81, n. 2, p. 233, doi. 10.1007/s40265-020-01443-4
- By:
- Publication type:
- Article
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
- Published in:
- Drugs, 2020, v. 80, n. 3, p. 285, doi. 10.1007/s40265-020-01257-4
- By:
- Publication type:
- Article
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
- Published in:
- Drugs, 2019, v. 79, n. 3, p. 271, doi. 10.1007/s40265-019-1055-2
- By:
- Publication type:
- Article
Antimicrobial resistance patterns of bacterial pathogens recovered from the urine of patients at Canadian hospitals from 2009 to 2020.
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 6, p. 1, doi. 10.1093/jacamr/dlac122
- By:
- Publication type:
- Article
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19.
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 1, p. 1, doi. 10.1093/jacamr/dlab197
- By:
- Publication type:
- Article
Frequency of MCR-1-mediated colistin resistance among Escherichia coli clinical isolates obtained from patients in Canadian hospitals (CANWARD 2008-2015).
- Published in:
- CMAJ Open, 2016, v. 4, n. 4, p. E641, doi. 10.9778/cmajo.20160080
- By:
- Publication type:
- Article
Evaluation of three MALDI‐TOF mass spectrometry libraries for the identification of filamentous fungi in three clinical microbiology laboratories in Manitoba, Canada.
- Published in:
- Mycoses, 2018, v. 61, n. 10, p. 743, doi. 10.1111/myc.12800
- By:
- Publication type:
- Article
Phenotypic and molecular characterization of Streptococcus pneumoniae serotype 3 isolates from blood and respiratory samples in Canada: CANWARD 2007–21.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 10, p. 2653, doi. 10.1093/jac/dkae272
- By:
- Publication type:
- Article
Genomic investigation of the most common Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i26, doi. 10.1093/jac/dkad067
- By:
- Publication type:
- Article
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i8, doi. 10.1093/jac/dkad065
- By:
- Publication type:
- Article
Comparison of PCV10, PCV13, PCV15, PCV20 and PPSV23 vaccine coverage of invasive Streptococcus pneumoniae isolate serotypes in Canada: the SAVE study, 2011–20.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i37, doi. 10.1093/jac/dkad068
- By:
- Publication type:
- Article
Streptococcus pneumoniae serotyping and antimicrobial susceptibility: assessment for vaccine efficacy in Canada after the introduction of PCV13.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i2, doi. 10.1093/jac/dkad064
- By:
- Publication type:
- Article
Analysis of MDR in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, p. i17, doi. 10.1093/jac/dkad066
- By:
- Publication type:
- Article
In vitro activity of sulopenem against 1880 bacterial pathogens isolated from Canadian patients with urinary tract infections (CANWARD, 2014-21).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 12, p. 3414, doi. 10.1093/jac/dkac333
- By:
- Publication type:
- Article
In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 11, p. 3035, doi. 10.1093/jac/dkac275
- By:
- Publication type:
- Article
PCV-15 and PPSV-23 coverage of invasive and respiratory tract Streptococcus pneumoniae, including MDR and XDR isolates: CANWARD 2007-20.
- Published in:
- 2022
- By:
- Publication type:
- journal article
ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18.
- Published in:
- 2021
- By:
- Publication type:
- journal article
In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Antimicrobial susceptibility of Clostridioides difficile isolated from diarrhoeal stool specimens of Canadian patients: summary of results from the Canadian Clostridioides difficile (CAN-DIFF) surveillance study from 2013 to 2017.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv64, doi. 10.1093/jac/dkz289
- By:
- Publication type:
- Article
Characterization of MRSA in Canada from 2007 to 2016.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv55, doi. 10.1093/jac/dkz288
- By:
- Publication type:
- Article
Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011–16 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv48, doi. 10.1093/jac/dkz287
- By:
- Publication type:
- Article
Comparison of antimicrobial resistance patterns in Streptococcus pneumoniae from respiratory and blood cultures in Canadian hospitals from 2007–16.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv39, doi. 10.1093/jac/dkz286
- By:
- Publication type:
- Article
Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007–16 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv32, doi. 10.1093/jac/dkz285
- By:
- Publication type:
- Article
Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007–16.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv22, doi. 10.1093/jac/dkz284
- By:
- Publication type:
- Article
42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2019, v. 74, p. iv5, doi. 10.1093/jac/dkz283
- By:
- Publication type:
- Article
Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Analysis of multidrug resistance in the predominant Streptococcus pneumoniae serotypes in Canada: the SAVE study, 2011-15.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Introduction to the SAVE study (2011-15): Streptococcus pneumoniae serotyping and antimicrobial susceptibility: Assessment for Vaccine Efficacy in Canada after the introduction of PCV-13.
- Published in:
- 2018
- By:
- Publication type:
- research
Characterization of MDR and XDR Streptococcus pneumoniae in Canada, 2007-13.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 8, p. 2199, doi. 10.1093/jac/dkv107
- By:
- Publication type:
- Article
Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 7, p. 1960, doi. 10.1093/jac/dkv061
- By:
- Publication type:
- Article
Pharmacodynamic activity of ertapenem versus genotypically characterized extended-spectrum β-lactamase (ESBL)-, KPC- or NDM-producing Escherichia coli with reduced susceptibility or resistance to ertapenem using an in vitro model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 9, p. 2448, doi. 10.1093/jac/dku149
- By:
- Publication type:
- Article
Evolution and molecular characterization of macrolide-resistant Streptococcus pneumoniae in Canada between 1998 and 2008.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 1, p. 59
- By:
- Publication type:
- Article
Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007–11.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i57
- By:
- Publication type:
- Article
Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i31
- By:
- Publication type:
- Article
Changes in fluoroquinolone resistance over 5 years (CANWARD 2007-11) in bacterial pathogens isolated in Canadian hospitals.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i47
- By:
- Publication type:
- Article
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007–11 study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i7
- By:
- Publication type:
- Article
Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007–11.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i23
- By:
- Publication type:
- Article
Changes in fluoroquinolone resistance over 5 years (CANWARD 2007–11) in bacterial pathogens isolated in Canadian hospitals.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. suppl_1, p. i39
- By:
- Publication type:
- Article